Table 2.
Parameter | Group | Time point | Mean±SD | ANOVA | Post hoc - Bonferroni correction | |||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
F | P | Pairs | MD (SE) | P | ||||
PPD | Control | BL | 7.0±1.1 | 176.35 | <0.0005* | BL versus 3M | 1.40 (0.13) | 0.0005* |
3M | 5.6±1.1 | BL versus 6M | 2.33 (0.13) | 0.0005* | ||||
6M | 4.7±1.0 | 3M versus 6M | 0.93 (0.12) | 0.0005* | ||||
Test | BL | 8.13±1.30 | 342.31 | <0.0005* | BL versus 3M | 2.73 (0.18) | 0.0005* | |
3M | 5.40±1.06 | BL versus 6M | 4.13 (0.17) | 0.0005* | ||||
6M | 4.00±0.93 | 3M versus 6M | 1.40 (0.13) | 0.0005* | ||||
CAL | Control | BL | 6.27±1.28 | 65.28 | <0.0005* | BL versus 3M | 1.13 (0.13) | 0.0005* |
3M | 5.13±1.19 | BL versus 6M | 1.60 (0.16) | 0.0005* | ||||
6M | 4.67±1.05 | 3M versus 6M | 0.47 (0.13) | 0.011* | ||||
Test | BL | 7.33±1.18 | 154.90 | <0.0005* | BL versus 3M | 1.80 (0.11) | 0.0005* | |
3M | 5.53±1.06 | BL versus 6M | 2.87 (0.19) | 0.0005* | ||||
6M | 4.47±0.74 | 3M versus 6M | 1.07 (0.18) | 0.0005* | ||||
DD | Control | BL | 1.84±0.86 | 10.32 | 0.002* | BL versus 3M | 0.41 (0.16) | 0.059 |
3M | 1.42±0.58 | BL versus 6M | 0.74 (0.21) | 0.009* | ||||
6M | 1.10±0.42 | 3M versus 6M | 0.33 (0.11) | 0.031 | ||||
Test | BL | 3.08±1.02 | 49.23 | <0.0005* | BL versus 3M | 0.59 (0.16) | 0.006* | |
3M | 2.49±1.02 | BL versus 6M | 1.72 (0.19) | 0.0005* | ||||
6M | 1.35±0.68 | 3M versus 6M | 1.14 (0.18) | 0.0005* |
*Significance set at α=0.05. Control: Control group treated with open flap debridement only; Test: Test group treated with open flap debridement and Platelet-rich fibrin matrix; ANOVA: Repeated measures ANOVA, adjusted for lack of sphericity by Greenhouse-Geisser correction. PPD: Probing pocket depth; CAL: Clinical attachment level; DD: Depth of the defect; BL: Baseline; 3M: 3 months posturgery; 6M: 6 months postsurgery; SD: Standard deviation; MD: Difference of means; SE: Standard error